Oncocyte secures $29.1 million to advance FDA assay
IRVINE, Calif. - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, has announced a funding round led by ...
manilatimes1h
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
MTX110 is a solubilized formulation of the histone deacetylase (HDAC) inhibitor, panobinostat. This proprietary formulation enables delivery of the product via convection-enhanced delivery (CED) at ...
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
MLive10h
Millions of doughnuts, baked goods sold nationwide recalled over listeria contamination concerns
The Food and Drug Administration recently shared more information about a voluntary recall last month involving more than two ...